News

Church’s Texas Chicken® Reintroduces Original Recipe Delight

Church’s Texas Chicken® Reintroduces Original Recipe Delight

Church’s Texas Chicken® Brings Back a Classic Flavor

Church’s Texas Chicken®, one of the leading quick-service chicken restaurant chains, has made an exciting announcement for its dedicated fans and new customers alike. The brand is reintroducing its iconic original recipe in all restaurants across the United States. This much-loved flavor, which has entertained taste buds for generations, is back and better than ever, inviting everyone to embark on a delectable journey celebrating this essential taste of the brand.

A Message from Church’s Texas Chicken Team

Joe Guith, CEO of Church’s Texas Chicken, expressed his enthusiasm about the reintroduction of this legendary recipe: "This is the recipe that started it all, crafted just for you. We are bringing back a piece of our heritage while paving the way for future growth. Our guests will appreciate the remarkable taste of our original recipe, which we believe will enhance our success and delight patrons for years to come."

More Than 70 Years of Flavorful Tradition

Church’s Texas Chicken has maintained a strong reputation for offering bold flavors and filling meals at affordable prices for over seven decades. The revival of the 1952 original recipe is a testament to the brand's commitment to quality and flavor. This rejuvenated recipe features richer, savory spices marinating the chicken deeply, enhancing not only taste but also experience, penetrating down to the bone.

The Insights from the Culinary Team

Kevin Houston, Head Chef at Church’s Texas Chicken, elaborated on what makes this original recipe extraordinary: "Our original recipe exemplifies the robust flavor that made us famous. Each piece is marinated deep and encased in a crispy, flaky breading. We're thrilled to reintroduce our OG recipe for our guests craving bold flavor, ensuring every bite showcases our beloved blend of spices. We warmly invite past patrons to rediscover our legendary chicken."

What Sets Church’s Original Recipe Apart?

The distinctive features of Church’s original recipe elevate it above competitors with its precise preparation and commitment to quality.

Key Highlights:

  • Deeply Marinated and Juicy: Every piece is marinated to ensure a burst of flavor with each bite.
  • Crispy and Crunchy: Hand-battered and double-breaded, the chicken delivers a flaky texture and satisfying crunch.
  • Flavorful to the Bone: The original recipe embodies everything loved about Church’s flavor—juicy and crunchy until the very last bite.
  • Simplified for Excellence: The streamlined recipe uses a single batter and breader for consistent quality in every serving.
  • Budget-Friendly Indulgence: Offering various meal choices such as 2PC Legs & Thighs or 2PC Tenders & Sauce, starting at just $2.99, and family packs at $10.99 for 10PC Legs & Thighs or 10PC Tenders & Sauce.

Join Our New Loyalty Program

Customers seeking rewards are invited to enroll in the Church’s Real Rewards™ program. This loyalty initiative enables guests to earn points during their visits, redeemable for various menu items, including the chance to redeem points for up to 16 pieces of chicken in a single order. Each dollar spent earns 10 points, and new members receive a complimentary chicken reward with their first purchase as part of the program.

For further details about the loyalty program, visit Church’s official website.

About Church’s Texas Chicken®

Established in 1952 by George W. Church Sr. in San Antonio, Texas, Church’s Texas Chicken® has become one of the foremost quick-service chicken restaurant chains globally, alongside its sister brand Texas Chicken™. The establishment is renowned for its Original and Spicy Chicken, hand-battered and double-breaded, in addition to an array of freshly baked Honey-Butter Biscuits™ and classic sides, all offered at superior value.

With a thriving presence boasting over 1,500 locations in 23 countries contributing to system-wide sales exceeding $1.4 billion, Church’s has firmly established itself in the fast-food industry. Since its acquisition by High Bluff Capital Partners and FS Investments in 2021, Church’s has continued to innovate while celebrating a remarkable 70-year legacy.

Frequently Asked Questions

What is the original recipe of Church’s Texas Chicken®?

The original recipe features deeply marinated chicken with a signature blend of spices, emphasizing juiciness and flavor.

How can customers join the Church’s Real Rewards™ program?

Customers can sign up for the Church’s Real Rewards™ program through the official Church’s website, where they can earn points for every purchase.

What types of meals can customers expect with the original recipe?

Customers can enjoy various offerings, including individual pieces and family packs featuring legs, thighs, and tenders at competitive prices.

How long has Church’s Texas Chicken® been in operation?

Church’s Texas Chicken has been serving customers since 1952, celebrating over 70 years of delicious meals and community engagement.

Why is the return of the original recipe significant?

The reintroduction of the original recipe symbolizes a return to the brand's roots while accommodating guest cravings for the classic flavors that define Church's Texas Chicken.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading